Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix

Proteome Science

Volumn 7, Issue , 2009, Pages 31-

  Delom, Frédéric ^a   Burt, Emma ^a   Hoischen, Alex ^b   Veltman, Joris ^b   Groet, Jürgen ^a   Cotter, Finbarr E ^a   Nizetic, Dean ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; COLLAGEN TYPE 6; HSA21 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOWN SYNDROME; EXTRACELLULAR MATRIX; FIBROBLAST; GENE DOSAGE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TRISOMY 21;

EID: 70350100470     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-7-31     Document Type: Article

References (35)

1. Epstein C. Down Syndrome. The metabolic and molecular bases of inherited disease 2001, 1223-1256. New York: McGraw-Hill, Scriver CRBA, Sly WS, Valle D.
2. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet 2004, 5:725-738. 10.1038/nrg1448, 15510164.
3. Mann DM. Alzheimer's disease and Down's syndrome. Histopathology 1988, 13:125-137. 10.1111/j.1365-2559.1988.tb02018.x, 2971602.
4. Adams MM, Erickson JD, Layde PM, Oakley GP. Down's syndrome. Recent trends in the United States. Jama 1981, 246:758-760. 10.1001/jama.246.7.758, 6454794.
5. Dunlop KA, Mulholland HC, Casey FA, Craig B, Gladstone DJ. A ten year review of atrioventricular septal defects. Cardiol Young 2004, 14:15-23. 10.1017/S1047951104001040, 15237666.
6. Kurnit DM, Aldridge JF, Neve RL, Matthysse S. Genetics of congenital heart malformations: a stochastic model. Ann N Y Acad Sci 1985, 450:191-204. 10.1111/j.1749-6632.1985.tb21493.x, 3160289.
7. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.
8. Stevens MV, Parker P, Vaillancourt RR, Camenisch TD. MEKK4 regulates developmental EMT in the embryonic heart. Dev Dyn 2006, 235:2761-2770. 10.1002/dvdy.20922, 16894626.
9. Jongewaard IN, Lauer RM, Behrendt DA, Patil S, Klewer SE. Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non-trisomic fibroblasts on type VI collagen. Am J Med Genet 2002, 109:298-305. 10.1002/ajmg.10413, 11992484.
10. Aumailley M, Specks U, Timpl R. Cell adhesion to type-VI collagen. Biochem Soc Trans 1991, 19:843-847.
11. Kitten GT, Kolker SJ, Krob SL, Klewer SE. Type VI collagen in the cardiac valves and connective tissue septa during heart development. Braz J Med Biol Res 1996, 29:1189-1193.
12. Klewer SE, Krob SL, Kolker SJ, Kitten GT. Expression of type VI collagen in the developing mouse heart. Dev Dyn 1998, 211:248-255. 10.1002/(SICI)1097-0177(199803)211:3<248::AID-AJA6>3.0.CO;2-H, 9520112.
13. Gittenberger-de Groot AC, Blom NM, Aoyama N, Sucov H, Wenink AC, Poelmann RE. The role of neural crest and epicardium-derived cells in conduction system formation. Novartis Found Symp 2003, 250:125-134. discussion 134-141, 276-129, full_text, 12956327.
14. Davies GE, Howard CM, Farrer MJ, Coleman MM, Bennett LB, Cullen LM, Wyse RK, Burn J, Williamson R, Kessling AM. Genetic variation in the COL6A1 region is associated with congenital heart defects in trisomy 21 (Down's syndrome). Ann Hum Genet 1995, 59:253-269. 10.1111/j.1469-1809.1995.tb00746.x, 7486833.
15. Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 2001, 3:91-101.
16. Xing L, Salas M, Lin CS, Zigman W, Silverman W, Subramaniyam S, Murty VV, Tycko B. Faithful tissue-specific expression of the human chromosome 21-linked COL6A1 gene in BAC-transgenic mice. Mamm Genome 2007, 18:113-122. 10.1007/s00335-006-0082-y, 17334655.
17. Canzonetta C, Mulligan C, Deutsch S, Ruf S, O'Doherty A, Lyle R, Borel C, Lin-Marq N, Delom F, Groet J. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet 2008, 83:388-400. 10.1016/j.ajhg.2008.08.012, 2556438, 18771760.
18. Raziuddin A, Sarkar FH, Dutkowski R, Shulman L, Ruddle FH, Gupta SL. Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. Proc Natl Acad Sci USA 1984, 81:5504-5508. 10.1073/pnas.81.17.5504, 391734, 6206498.
19. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007, 2:329-333. 10.1038/nprot.2007.30, 17406593.
20. Delom F, Emadali A, Cocolakis E, Lebrun JJ, Nantel A, Chevet E. Calnexin-dependent regulation of tunicamycin-induced apoptosis in breast carcinoma MCF-7 cells. Cell Death Differ 2007, 14:586-596. 10.1038/sj.cdd.4402012, 16858427.
21. Quarello E, Guimiot F, Moalic JM, Simoneau M, Ville Y, Delezoide AL. Quantitative evaluation of collagen type VI and SOD gene expression in the nuchal skin of human fetuses with trisomy 21. Prenat Diagn 2007, 27:926-931. 10.1002/pd.1803, 17602442.
22. Kimura M, Cao X, Skurnick J, Cody M, Soteropoulos P, Aviv A. Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. Free Radic Biol Med 2005, 39:374-380. 10.1016/j.freeradbiomed.2005.03.023, 15993336.
23. Fung ET, Thulasiraman V, Weinberger SR, Dalmasso EA. Protein biochips for differential profiling. Curr Opin Biotechnol 2001, 12:65-69. 10.1016/S0958-1669(00)00167-1, 11167075.
24. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. A chromosome 21 critical region does not cause specific down syndrome phenotypes. Science 2004, 306:687-690. 10.1126/science.1098992, 15499018.
25. Shapiro BL. Down syndrome-a disruption of homeostasis. Am J Med Genet 1983, 14:241-269. 10.1002/ajmg.1320140206, 6220605.
26. Altafaj X, Dierssen M, Baamonde C, Marti E, Visa J, Guimera J, Oset M, Gonzalez JR, Florez J, Fillat C, Estivill X. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet 2001, 10:1915-1923. 10.1093/hmg/10.18.1915, 11555628.
27. Chrast R, Scott HS, Madani R, Huber L, Wolfer DP, Prinz M, Aguzzi A, Lipp HP, Antonarakis SE. Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. Hum Mol Genet 2000, 9:1853-1864. 10.1093/hmg/9.12.1853, 10915774.
28. Harris-Cerruti C, Kamsler A, Kaplan B, Lamb B, Segal M, Groner Y. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutaze and amyloid precursor protein. Eur J Neurosci 2004, 19:1174-1190. 10.1111/j.1460-9568.2004.03188.x, 15016076.
29. Sumarsono SH, Wilson TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A, Kola I. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature 1996, 379:534-537. 10.1038/379534a0, 8596630.
30. Hernandez D, Mee PJ, Martin JE, Tybulewicz VL, Fisher EM. Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. Hum Mol Genet 1999, 8:923-933. 10.1093/hmg/8.5.923, 10196383.
31. Shinohara T, Tomizuka K, Miyabara S, Takehara S, Kazuki Y, Inoue J, Katoh M, Nakane H, Iino A, Ohguma A. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum Mol Genet 2001, 10:1163-1175. 10.1093/hmg/10.11.1163, 11371509.
32. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D. An aneuploid mouse strain carrying human chromosome 21 with down syndrome phenotypes. Science 2005, 309:2033-2037. 10.1126/science.1114535, 1378183, 16179473.
33. Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 1995, 77:1-6.
34. Schneider EL, Epstein CJ. Replication rate and lifespan of cultured fibroblasts in Down's syndrome. Proc Soc Exp Biol Med 1972, 141:1092-1094.
35. de Haan JB, Cristiano F, Iannello R, Bladier C, Kelner MJ, Kola I. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum Mol Genet 1996, 5:283-292. 10.1093/hmg/5.2.283, 8824885.